NFKB1 and type 2 diabetes mellitus: Furthermore, the effects of SITG were confirmed by a reduction in NF-κB levels in the T2DM + SITG10 (2.135 ± 0.127, p < 0.01) and T2DM + SITG30 (2.027 ± 0.047) groups compared to the T2DM group.